drugset / Trial / NCT01355159

High Dose Folic Acid Supplementation Throughout Pregnancy for Preeclampsia Prevention

NCT01355159

RandomizedParallel-groupQuadruple-blindPrevention

Summary

To determine the efficacy of high dose folic acid supplementation for prevention of preeclampsia in women with at least one risk factor: pre-existing hypertension, pre-pregnancy diabetes (type 1 or 2), twin pregnancy, preeclampsia in a previous pregnancy, or body mass index ≥35. It was hypothesized that high dose (4.0 mg per day) supplementation starting in early pregnancy and continued throughout the entire pregnancy will lower the incidence of preeclampsia in pregnant women at high risk of developing preeclampsia.

Timeline

Start
2011-04
Primary completion
2016-07
Completion
2016-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject folic acid Other / unclassified 4 mg Oral

Indications